AVITA Medical, Inc.
RCELNASDAQHealthcare● Active
$4.21
+$0.05(+1.20%)
Market Cap$104588609
P/E Ratio—
52W High$7.12
52W Low$3.22
AVITA Medical, Inc. (RCEL) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RCEL · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $71.61M | $64.25M | $50.14M | $34.42M | $33.02M |
| Cost of Revenue | $12.79M | $9.09M | $7.78M | $6.04M | $6.10M |
| Gross Profit | $58.82M | $55.16M | $42.36M | $28.38M | $26.92M |
| Gross Margin %(computed) | 82.13% | 85.85% | 84.48% | 82.45% | 81.52% |
| Operating Expenses | |||||
| R&D Expenses | $20.84M | $20.36M | $20.82M | $13.86M | $15.67M |
| G&A Expenses | $27.37M | $33.20M | $28.33M | $23.33M | $20.95M |
| Total Operating Expenses | $100.75M | $111.75M | $85.02M | $55.88M | $52.04M |
| Operating Income | ($41.93M) | ($56.59M) | ($42.66M) | ($27.50M) | ($25.12M) |
| Operating Margin %(computed) | -58.56% | -88.08% | -85.07% | -79.91% | -76.06% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $5.00M | $5.36M | $1.14M | $0.02M | $0.03M |
| Income Before Tax | ($48.58M) | ($61.79M) | ($35.31M) | ($26.63M) | ($25.10M) |
| Income Tax Expense | $0.01M | $0.05M | $0.07M | $0.04M | $0.04M |
| Net Income | ($48.59M) | ($61.84M) | ($35.38M) | ($26.66M) | ($25.14M) |
| Net Margin %(computed) | -67.85% | -96.26% | -70.56% | -77.47% | -76.13% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.74 | $-2.39 | $-1.40 | $-1.07 | $-1.03 |
| Wtd Avg Shares | 27.86M | 25.88M | 25.33M | 25.00M | 24.36M |
| EBITDA | ($39.59M) | ($55.30M) | ($33.54M) | ($26.05M) | ($24.40M) |
| EBITDA Margin %(computed) | -55.28% | -86.07% | -66.89% | -75.67% | -73.89% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more AVITA Medical, Inc. data
About AVITA Medical, Inc. (RCEL) Income Statement
AVITA Medical, Inc. (RCEL) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, RCEL reported revenue of $0.07B, gross profit of $0.06B (gross margin 82.13%), and net income of ($0.05B) — a net profit margin of -67.85%.
Frequently asked questions
RCEL · 4 questionsAVITA Medical, Inc. (RCEL) reported revenue of $0.07B for 2025, up 11.5% year-over-year.
RCEL revenueRCEL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09